SCHEMBL43777

SCHEMBL43777

O=C(OCCS(=O)(=O)CCOC(=O)ON1C(=O)CCC1=O)ON1C(=O)CCC1=O

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PARL Q9H300 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1062744 1.00 PARL (0.32) PARL
SCHEMBL16330094 0.92 ALDH1A1 (0.32)
SCHEMBL14181982 0.87
SCHEMBL367999 0.87 ALDH1A1 (0.30) PARL
SCHEMBL20672994 0.85 KMT2A (0.30)
SCHEMBL7027419 0.84
SCHEMBL16125860 0.83
SCHEMBL1309141 0.83
SCHEMBL9228581 0.81 PARL (0.31) PARL
SCHEMBL12237277 0.81 PARL (0.49) PARL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3679 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4739336-A2 METHOD FOR IMMOBILIZATION OF PROTEINS Perseo Pharma AG (CH) 2026-05-13 EP claimed
EP-4739338-A1 FUNCTIONALIZED DISACCHARIDASE COMPOSITIONS Perseo Pharma AG (CH) 2026-05-13 EP claimed
EP-4739348-A1 BIOCATALYTICAL COMPOSITIONS Perseo Pharma AG (CH) 2026-05-13 EP claimed
EP-4739337-A1 FUNCTIONALIZED BIOCATALYTICAL COMPOSITIONS COMPRISING PANCREATIC ENZYMES Perseo Pharma AG (CH) 2026-05-13 EP claimed
EP-4716755-A1 RNA PROBING AND AMPLIFICATION METHODS FOR SINGLE CELL ANALYSIS ON FIXED CELLS Becton, Dickinson and Company (US) 2026-04-01 EP claimed
EP-4689130-A2 METHODS AND COMPOSITIONS FOR ENHANCED EXPRESSION OF EXOGENOUS CASEINS IN TRANSGENIC PLANTS Mozza Foods Inc. (US) 2026-02-11 EP claimed
EP-4605017-A1 ANTIFIBROTIC FORMULATION FOR OPHTHALMIC TREATMENT Universität Rostock (DE) 2025-08-27 EP claimed
EP-4594520-A2 COMPOSITIONS CONTAINING OLIGONUCLEOTIDES WITH THERANOSTIC APPLICATIONS Sixfold Bioscience Ltd. (GB) 2025-08-06 EP claimed
WO-2025081242-A1 EXTRACELLULAR VESICLE COMPOSITIONS AND USES THEREOF INOVIQ Ltd (AU) 2025-04-24 WO claimed
CN-112533640-B Targeting of M2-type tumor-associated macrophages using melittin-based apoptosis-inducing peptides 双亥生命科学株式会社 2025-02-28 CN claimed
EP-0267204-B1 IMMUNOPOTENTIATION BIOENTERPRISES PTY LTD (AU) 1993-12-08 EP claimed
EP-0220030-B1 ORAL DELIVERY SYSTEM BIOTECHNOLOGY AUSTRALIA PTY. LTD. (AU) 1991-06-19 EP claimed
EP-0267204-A4 IMMUNOPOTENTIATION. BIOENTPR PTY LTD (AU) 1989-03-22 EP claimed
EP-0267204-A1 IMMUNOPOTENTIATION. BIOENTERPRISES PTY LTD (AU) 1988-05-18 EP claimed
WO-1987006590-A1 IMMUNOPOTENTIATION BIOENTERPRISES PTY. LTD. (AU) 1987-11-05 WO claimed
EP-0220030-A2 Oral delivery system BIOTECHNOLOGY AUSTRALIA PTY. LTD. (AU) 1987-04-29 EP claimed
WO-1987002251-A1 ORAL DELIVERY OF BIOLOGICALLY ACTIVE SUBSTANCES BOUND TO VITAMIN B12, OR ANALOGUES THEREOF BIOTECHNOLOGY AUSTRALIA PTY. LTD. (AU) 1987-04-23 WO claimed
US-4608246-A Testing for a blood group immunological reaction IMMUCOR, INC. (US) 1986-08-26 US claimed
EP-0157797-A1 DETECTING AN IMMUNOLOGICAL REACTION WITH ACTIVATED RED BLOOD CELLS (ERYTHROCYTES) IMMUCOR, INC. (US) 1985-10-16 EP claimed
WO-1985001354-A1 DETECTING AN IMMUNOLOGICAL REACTION WITH ACTIVATED RED BLOOD CELLS (ERYTHROCYTES) IMMUCOR, INC. (US) 1985-03-28 WO claimed